LAUREN PASQUARELLI: Open Payments
NPI 1578128559 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,764 in 157 payments from 20 companies in 2025. Trend: 2023 $2,667 · 2024 $1,792 · 2025 $5,764
Food & beverage: $5,264Consulting: $500
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 36 | $1,966 |
| ABBVIE INC. | 27 | $662 |
| Galderma Laboratories, L.P. | 22 | $612 |
| Janssen Biotech, Inc. | 13 | $537 |
| GENZYME CORPORATION | 8 | $491 |
| Novartis Pharmaceuticals Corporation | 16 | $307 |
| Regeneron Healthcare Solutions, Inc. | 4 | $274 |
| Botanix SB Inc | 6 | $227 |
| Amgen Inc. | 7 | $159 |
| Journey Medical Corporation | 1 | $118 |
Products named: ADBRY, DUPIXENT, TREMFYA, SKYRIZI, NEMLUVIO, COSENTYX, ANZUPGO, SOFDRA.
Industry payments across NY — which companies pay providers there.
